Inovio Pharmaceuticals, Inc.

NASDAQ:INO

Biotechnology

Healthcare
$1.71 -0.90%

-$0.01 today

Market cap
$118.15M
Beta
1.49
P/E (TTM)
-8.9
EPS (TTM)
-$0.12
52W Low $1.03High $2.98

Volume 9.92M

Average 2.73M

Balance Sheet

Inspect the capital base behind the business.

Assets

$74.31M

FY 2025 · Annual

-34.4% YoY

Liabilities

$50.21M

FY 2025 · Annual

+12.4% YoY

Equity

$24.10M

FY 2025 · Annual

-64.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents71.14M46.33M14.31M65.81M44.27M
Short-term Investments330.17M206.67M130.98M28.3M14.24M
Net Receivables8.03M11.74M2.41M1.2M450
Inventory00000
Other Current Assets261.19K30.38M20.43K00
Total Current Assets448.44M315.24M153.11M97.83M61.12M
Property, Plant & Equipment (Net)29.02M17.96M14.45M11.77M9.07M
Goodwill10.51M10.51M000
Intangible Assets2.63M2.13M000
Long-term Investments3.91M2.01M2.78M1.61M2.1M
Tax Assets00000
Other Non-current Assets1.43M684.04K605.32K1.98M2.01M
Total Non-current Assets47.5M33.29M17.84M15.37M13.19M
Total Assets495.94M348.53M170.95M113.2M74.31M
Account Payables27.97M21.08M4.65M6.44M2.62M
Short-term Debt0016.77M00
Tax Payables00000
Deferred Revenue21.63K0000
Other Current Liabilities20.71M15.14M9.95M23.26M36.44M
Total Current Liabilities65.74M96.87M42.57M35.33M43.67M
Long-term Debt14.96M16.61M000
Deferred Tax Liabilities32.05K32.05K000
Deferred Revenue (Non-current)64.36K0000
Other Non-current Liabilities14.83K0000
Total Non-current Liabilities30.53M29.3M11.03M9.37M6.55M
Total Liabilities96.27M126.17M53.6M44.69M50.21M
Common Stock217.38K21.09K22.79K36.1K69K
Retained Earnings(1.21B)(1.49B)(1.62B)(1.73B)(1.82B)
Accumulated OCI(282.24K)(698.74K)(662.6K)(675.67K)(637.96K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity399.67M222.36M117.35M68.5M24.1M
Total Debt33.02M32.07M30.21M11.87M9.37M
Net Debt(38.12M)(14.25M)15.9M(53.95M)(34.91M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$26.3M
Short-term Investments$11.4M
Other Current$1.8M
Total Current Assets$39.4M
PP&E (Net)$8.3M
Other Non-current$2.0M
Total Non-current Assets$10.3M
Total Assets$49.8M

Analysis

Selected assets total $49.8M for Latest. The largest visible component is Cash & Equivalents at $26.3M, about 52.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
FWPFWP filingNov 6, 2026
424B5424B5 filingNov 6, 2026
8-KCurrent reportNov 5, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
424B5424B5 filingNov 5, 2026

How much cash does INO have?

Inovio Pharmaceuticals, Inc. (INO) reported $44.27M in cash and equivalents in fiscal 2025.

How much debt does INO carry?

Inovio Pharmaceuticals, Inc. (INO) reported $9.37M of total debt, with net debt of -$34.91M.